Potential delays in the receipt of acute therapy may be a factor that contributes to poorer outcomes for young women. Possible explanations for the delay in treatment and the use of early reperfusion procedures for women have included both patient factors such as older age, nonwhite race, comorbidity, the presence of atypical symptoms, the delay in presentation, and organizational factors, as well, such as the time of presentation Background-Sex disparities in reperfusion therapy for patients with acute ST-segment-elevation myocardial infarction have been documented. However, little is known about whether these patterns exist in the comparison of young women with men. Methods and Results-We examined sex differences in rates, types of reperfusion therapy, and proportion of patients exceeding American Heart Association reperfusion time guidelines for ST-segment-elevation myocardial infarction in a prospective observational cohort study (2008)(2009)(2010)(2011)(2012) of 1465 patients 18 to 55 years of age, as part of the US Variations in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study at 103 hospitals enrolling in a 2:1 ratio of women to men. Of the 1238 patients eligible for reperfusion, women were more likely to be untreated than men (9% versus 4%, P=0.002). There was no difference in reperfusion strategy for the 695 women and 458 men treated. Women were more likely to exceed in-hospital and transfer time guidelines for percutaneous coronary intervention than men (41% versus 29%; odds ratio, 1.65; 95% confidence interval, 1.27-2.16), more so when transferred (67% versus 44%; odds ratio, 2.63; 95% confidence interval, 1.17-4.07); and more likely to exceed door-to-needle times (67% versus 37%; odds ratio, 2.62; 95% confidence interval, 1.23-2.18). After adjustment for sociodemographic, clinical, and organizational factors, sex remained an important factor in exceeding reperfusion guidelines (odds ratio, 1.72; 95% confidence interval, 1.28-2.33). Conclusions-Young women with ST-segment-elevation myocardial infarction are less likely to receive reperfusion therapy and more likely to have reperfusion delays than similarly aged men. Sex disparities are more pronounced among patients transferred to percutaneous coronary intervention institutions or who received fibrinolytic therapy.
arly reperfusion therapy in the treatment of patients with ST-segment-elevation myocardial infarction (STEMI) is critical to maximize health outcomes. [1] [2] [3] In the past decade, studies have documented sex disparities in the administration of reperfusion therapies for patients with STEMI, with women being more likely to experience delays in treatment and less likely to receive appropriate therapies. [4] [5] [6] [7] [8] [9] [10] [11] However, relatively little is known about the degree and influence of these delays for young women (<55 years) in part, because they exhibit a lower incidence of STEMI and limited representation in previous studies 12, 13 This represents an important gap, because young women have poorer outcomes following acute myocardial infarction (AMI) in comparison with similarly aged men. and transfer from another hospital. 19, 20 Recent evidence suggests that young women are more likely to present without chest pain, 21, 22 and it is possible that their atypical presentation may lead to a delay in seeking treatment, which can be further compounded by a delay in recognition and diagnosis of the AMI by prehospital personnel and emergency physicians. This cascade of prehospital and emergency department delays may result in delayed reperfusion strategies, prolonged ischemic time, and poor outcomes. Finally, a prevalence of comorbidity and a concern for adverse contraindications to fibrinolytic therapy in women in comparison with similarly aged men may preclude treatment with timely fibrinolytic therapy. 23 Previous studies provide valuable insights into factors that may contribute to delays in treatment, but have predominately been limited to retrospective analyses using large data registries, often including mixed AMI types, with incomplete data regarding socioeconomic and clinical factors and excluded transfers from non-percutaneous coronary intervention (PCI) centers. [24] [25] [26] [27] [28] [29] To better understand the use of and barriers to acute reperfusion in STEMI among young women, we used data from the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study, which was specifically designed to address fundamental questions regarding the care of young women with AMI in a large geographically diverse prospectively collected data set. 30 We sought to determine sex differences in the rates of reperfusion and the time and type of reperfusion strategy within the practice guideline-recommended time frames. Thus, this study sought to determine if sex disparities exist and to provide a foundation for efforts to improve the quality of care and outcomes for young women with STEMI.
Methods

Study Population
To examine adherence to the American College of Cardiology/ American Heart Association door-to-balloon and door-to-needle practice guidelines, we used the US VIRGO study population of 2985 patients enrolled from 103 geographically diverse sites ( Figure 1 ) from August 21, 2008 to January 5, 2012. We excluded the Spanish and Australia component of VIRGO because of the lack of specific time intervals and to limit variability in cultural and healthcare delivery system-mediated factors. The VIRGO methodology has been described previously. 30 In brief, eligible patients were those aged 18 to 55 years who had abnormal cardiac biomarkers, with at least 1 biomarker above the 99th percentile of the upper reference limit within 24 hours of admission. Additional evidence of AMI was required, including at least one of the following: symptoms of ischemia, ECG changes indicative of new ischemia (new ST-T changes or the development of pathological Q waves). Patients must have presented directly to the enrolling PCI site or have been transferred within the first 24 hours of presentation to ensure that primary clinical decision making occurred at the enrolling site. Exclusion criteria included the inability to speak either English or Spanish, the development of elevated cardiac markers as a result of elective coronary revascularization, physical trauma, or surgery, and the inability to provide consent or provide contact information for follow-up. VIRGO enrolled a 2:1 ratio of women to men. After every 2 women enrolled, the next consecutive male patient presenting to the hospital with an AMI was enrolled. The Yale Human Investigation Committee and institutional review boards at each institution approved this study, and all patients gave informed consent.
Data Collection and Variables
Trained personnel conducted interviews and reviewed medical charts during the index AMI admission for the following: (1) , and smoking status in past 30 days), hemodynamic instability (ventricular tachycardia/defibrillation, blood pressure <90 mm Hg), the presence of a prehospital ECG and presentation during off hours (5 pm to 7 am). The time of first hospital arrival, the qualifying ECG that prompted cardiac catheterization laboratory activation either in the emergency department or field, and primary PCI balloon inflation or initiation of fibrinolytic therapy were recorded. Eligibility for reperfusion was defined as ≥30 minutes of chest pain within 12 hours of presentation and ST elevation >1 mm in ≥2 consecutive leads or left bundle-branch block that was new or of unknown duration.
Statistical Analysis
Time (in minutes) to ECG, fibrinolytic therapy, and balloon inflation were calculated. Twenty-three patients had activations from the field and went directly to the catheterization laboratory; their door-to-ECG times were set to zero, and there were 13 women and 10 men (P=0.53). Median times between sexes were compared by using a Wilcoxon rank sum test. The proportions of patients meeting guidelines for ECG (within 10 minutes), fibrinolytic therapy (within 30 minutes), and PCI (within 90 minutes for in-house management and 120 minutes for transfers) were calculated. We included specific time intervals from ECG-to-laboratory and laboratory-to-balloon for patients presenting at PCI sites and transferred from non-PCI sites. Odds ratios and 95% confidence intervals were calculated with men being the referent group. We used logistic models to evaluate the importance of sex on exceeding the practice time guidelines for reperfusion times. Four models were run that incrementally added covariates. The first model included only sex. Model 2 then adjusted for sociodemographics (age, race), prior heart disease (AMI, CABG, PCI), and the presence of cardiovascular risk factors (diabetes mellitus, obesity, hypertension, hypercholesterolemia, and smoking). Model 3 included additional clinical factors that have been previously identified as potential reasons for the variation in time to perfusion as covariates: transfer status, ECG before arrival, the presence of left bundle-branch block, the presence of atypical symptoms, presentation within 6 hours of symptom onset, and hemodynamic instability on arrival (cardiac arrest, blood pressure <90 mm Hg). Model 4 added receipt of fibrinolytic therapy. By adjusting for patient and system factors incrementally, we attempted to understand the contribution of sex to reperfusion times. The P values were 2-sided and <0.05 was considered statistically significant. All analyses were completed with the use of SAS 9.3 (SAS Institute Inc, Cary, NC). 
Results
Patient Characteristics
A total of 3572 patients were enrolled overall in the VIRGO study; 2985 patients were enrolled in the US cohort. Our analyses were restricted to the 1465 patients presenting with STEMI. Figure 2 depicts the flow diagram of patients entered into the study. Forty-nine percent had an acute STEMI, less often in women than in men (46% versus 57%; P<0.001). Among 1238 patients eligible for reperfusion, a total of 1153 (93%) received this therapy (n=695 women, n=458 men). Almost all patients (90%) received PCI. Of the 10% receiving fibrinolytic therapy, 94% received this therapy before transfer to the enrolling site.
In our study sample of those who were eligible and received reperfusion (1153), women and men were similar in terms of age and education level. More women were black, and men were more likely to be Hispanic, married, and employed (Table 1 ). Both sexes had major comorbidities and risk factors for cardiovascular disease; women were more likely to be diabetic, to be obese, and to use tobacco. Only 4% in each group had no identifiable risk factors. Women were more likely than men to present with atypical chest pain or no symptoms (16% versus 10%; P=0.008) and more likely to present >6 hours after symptom onset (35% versus 23%; P=0.002).
Reperfusion and Type
Of the 1238 patients that were eligible for reperfusion, 85 (7%) did not receive therapy ( Figure 2 ). Characteristics of the eligible patients who received reperfusion versus those who did not receive reperfusion are presented in Table I in the online-only Data Supplement. The characteristics of patients who did not receive reperfusion by sex can be found in Table  II 
Time to Reperfusion
Overall and sex-specific median times from door to balloon and door to needle with quartile 1 (Q1) to quartile 3 (Q3) are presented in Table 2 . The observed proportion of men and women exceeding recommended time frames, unadjusted odds ratios, and 95% confidence intervals are presented in Table 3 . Twenty-eight percent of women and 24% of men received an ECG >10 minutes after arrival. The median time from door-to-balloon inflation was longer for women than for men (88 minutes; Q1-Q3, 63-139) in comparison with men (80 minutes Q1-Q3, 58-115; P=0.002). Women were more likely to exceed the recommended time guidelines for PCI than men, 41% versus 29% (unadjusted odds ratio, 1.65; 95% CI, 1.27-2.16). Primarily patients requiring transfer accounted for the differences in reperfusion times. Overall, median door-to-balloon time for women presenting to PCI sites was 73 minutes in comparison with 65 minutes for men (P=0.002), but the unadjusted odds of exceeding the recommended time frame for reperfusion were not significant (27% of women versus 21% of men [unadjusted odds ratio, 1.39; 95% CI, 0.96-2.01]). However, in transferred patients, women had a median time to perfusion of 145 minutes in comparison Tables 2  and 3 ).
In a model only considering sex (model 1), women had 1.70 times the odds of exceeding reperfusion goals (including nontransfer and transfer door-to-balloon times for PCI and fibrinolysis door-to-needle times) in comparison with men (95% CI, 1.32-2.18). Sequential adjustment for sociodemographic factors, previous heart disease, and risk factors (model 2) appeared to slightly attenuate the association, with women having only 1.61 times the odds of delay in comparison with men (95% CI, 1.24-2.08). However, with further adjustment for clinical factors (model 3) and transfer status (model 4), sex remained a significant factor in delay in meeting reperfusion goals and the odds of women exceeding the reperfusion goals increased to 1.72 (95% CI, 1.28-2.33; Figure 3 ).
Mortality Rates
Mortality rates for patients exceeding the recommended guidelines was higher than for those that did not exceed guidelines at both 1 month (6 [ Given the small number of deaths, an adjusted analysis of mortality could not be performed.
Discussion
This prospective observational study is the first to demonstrate that young women presenting with STEMI are both less likely to receive reperfusion therapy and more prone to experience delays in receiving reperfusion therapies in comparison with similarly aged men. Additionally, women with >50% occlusion documented on cardiac catheterization were less likely to receive reperfusion than men. After adjustment for confounders, including sociodemographics, comorbidities, and clinical factors, female sex persisted as a significant factor in the delay of reperfusion therapy.
These findings provide 2 novel insights. First, our contemporary data provide evidence that delays in reperfusion therapy for STEMI occur in young women, findings that have been documented in older women for nearly a decade, [31] [32] [33] and only recently reported in a smaller study of young women with AMI in Canada. 34 Second, the observed disparity in treatment for STEMI occurs more often in young women receiving fibrinolytic therapy and in women requiring transfer to PCI centers.
A similar proportion of men and women received an ECG within 10 minutes, suggesting no sex difference in the suspicion of AMI. This was unexpected because delayed recognition, either due to atypical presentation on the part of the patient or physician bias, is often attributable to the delay in treatment. 35 Our results also differ from reports derived from international registries where longer door-to-ECG times were observed in women. 26, 34, 35 Delays for women were observed in ECG-to-balloon inflation time suggesting that the process was hampered by difficulties in implementing procedures leading up to arrival to the catheterization laboratory or technical challenges in women in comparison with men at PCI sites. However, in this observational study, we cannot be certain of the underlying root cause.
The most significant clinically relevant delays were observed in sex-specific delays in ECG to reperfusion time for women receiving fibrinolytic therapy (door-to-needle) and in transfer times for PCI patients (door-to-balloon). Women who were transferred from an outside facility were >2.6 times more likely than men to exceed the reperfusion guidelines of 120 minutes. In 2002, Angeja et al 19 reported that one of the strongest independent predictors of door-to-balloon delay was hospital transfer. Female sex was noted as a weaker predictor. Subsequent studies examining sex differences in performance measures for large STEMI populations, however, eliminated transfers from their analyses. 24, [26] [27] [28] [29] Thus, 12 years later, it is critical that we revisit the processes related to quality measures in transfers for women needing PCI.
Potential delays could occur at multiple intervals, including emergency physician interpretation of the ECG, barriers in the activation process, obtaining consent, referral hospital acceptance, or during the reevaluation process in the receiving facility. Although current recommendations call for fibrinolytic therapy within 30 minutes of delays in transfer or laboratory activation are expected, 36 this did not always occur. Our findings underscore the importance of focusing efforts on identifying the sex-specific causes of delay, because shorter times to reperfusion improve mortality. 28, 37 Reducing variation in practices by developing standards with protocol-driven decisionmaking algorithms for patients presenting with STEMIs to non-PCI sites has been shown to improve reperfusion times. 38 This would include a streamlined approach such as 1 call to the accepting site, timely emergency medical services (EMS) transportation direct to a cardiac catheterization laboratory, established guidelines for each interval, continuous quality review processes, and timely feedback mechanisms. The performance of prehospital ECGs and the facilitation of direct transport to primary PCI facilities would be another solution. Delays in EMS transfers have been documented for women despite their having symptoms similar to men. 39 EMS education to obtain prehospital ECGs and STEMI field activation to reduce ischemia time could improve the time to reperfusion for men and women and potentially eliminate any unmeasured sex biases. EMS field activation of the catheterization laboratory is associated with shorter door-to-balloon times than emergency department activation for either walk-in patients or patients arriving by EMS without field activation. 40, 41 Our data show that there is room for improvement for both sexes, because 44% of men also exceeded the recommended guidelines when transferred. EMS field activation and regionalization of care are particularly promising in light of the new American Heart Association/American College of Cardiology guidelines that emphasize reducing ischemia time by measuring the delays in Field Medical Contact in an attempt to reduce field delays, 36 and improve long-term outcomes. 42 Other factors often associated with exceeding the reperfusion guidelines are delayed presentation (>6 hours), and the presence of atypical symptoms, as well. Both factors were present predominantly in women in comparison with men. Recent reports have put greater emphasis on reducing ischemia time by addressing the delays to presentation as opposed to focusing just on the door-to-balloon time. 36 Also, various registries have demonstrated that adjusting for atypical symptoms had the greatest effect in narrowing sex differences among young patients. 35 Atypical symptoms are also often a reason for patient's delay in seeking medical attention, and delay in recognition by emergency providers, as well, and should be incorporated in these education efforts. Our results support focusing on community strategies that address education about symptoms of AMI, barriers to early presentation, and delays in transfers.
Approximately 96% of the patients in our study had ≥1 traditional cardiac risk factors. These rates are higher than reported in the general population. 43 This is important, because young women are often perceived to be at low risk for cardiac events owing to high levels of estrogen. Other population studies have reported similar high rates of risk factors, particularly diabetes mellitus, in young populations with premature AMI. 34, 44 The American Heart Association recommends obtaining an ECG as part of the standard evaluation of chest discomfort regardless of age and sex. Our data support this recommendation, particularly in the presence of any cardiac risk factors.
Evidence exists that young women have a 2-fold higher in-hospital mortality rate following an AMI than men have, 14 and, of those women who survive an AMI, their subsequent risk of mortality is ≈50% higher. 45 Recent reports corroborate this increased risk of dying within 30 days of hospital discharge for young women ≤55 years of age in comparison with similarly aged men. 46, 47 Although the mechanisms underlying this excess risk are not entirely clear, delayed reperfusion and prolonged ischemic times may be 1 explanation, suggesting that strategies to shorten hospital arrival time and decreasing transfer times between facilities may improve health outcomes for women. Results from the Gender and Sex Determinants of Cardiovascular Disease: From Bench to Beyond-Premature Acute Coronary Syndrome (GENESIS-PRAXY) study noted that, regardless of sex, young patients who exceeded the American Heart Association/American College of Cardiology guidelines were more than twice as likely to experience a major adverse cardiovascular event during the year following their AMI. 48 Our results support these findings, because the unadjusted rates of dying were greater if the recommended guidelines for reperfusion were exceeded. Unfortunately, the small numbers of deaths overall preclude any adjustments including sex or other factors.
There are limitations to our study. All patients who were enrolled survived their AMI, and we have no data regarding patients who died either before arrival or during their initial hospitalization before consent, or were too sick to consent.
Previous research has demonstrated that men are more likely to die prehospital owing to the higher incidence of ventricular arrhythmias. 49, 50 The data were collected from chart extraction. To minimize errors and omissions, we worked closely with each site coordinator and monitored each submission to maintain the quality and completeness of all variables. Planned chart extraction, however, offers more opportunities to include important variables and enhance completeness than data analysis from registries. We did not perform any qualitative interviews with the emergency department staff, referral or receiving institution staff. We therefore cannot definitively identify the specific processes responsible for delay. In addition, after every 2 women, we enrolled the next consecutive male that presented and consented to be enrolled. Finally our low overall mortality rates prevent forming definitive conclusions regarding mortality and exceeding reperfusion guidelines. However, in light of these limitations, we provide compelling evidence of female sex as an important predictor of reperfusion delay in young patients presenting with STEMI.
Conclusion
Young women with STEMI are less likely to receive reperfusion therapy, and more likely to have reperfusion delays than similarly aged men. Sex disparities are more pronounced among patients who are transferred to PCI institutions or receive fibrinolytic therapy. Interventions that reduce variations in practice at the community, institutional, and regional levels for younger patients, particularly women, with AMI are needed.
